For the quarter ending 2025-09-30, NWBO made $200,000 in revenue. -$26,550,000 in net income. Net profit margin of -13275.00%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Research and other | 200,000 | 131,000 | 375,000 | 257,500 |
| Research and development | 7,450,000 | 7,430,000 | 8,351,000 | 9,232,500 |
| General and administrative | 7,070,000 | 7,480,000 | 9,335,000 | 8,146,500 |
| Total operating costs and expenses | 14,520,000 | 14,910,000 | 17,686,000 | 17,379,000 |
| Foreign currency transaction gain (loss) | - | 3,640,000 | 1,898,000 | -2,131,500 |
| Loss from operations | -14,320,000 | -14,779,000 | -17,311,000 | -17,121,500 |
| Change in fair value of derivative liabilities | -3,332,000 | 724,000 | 1,280,000 | -227,500 |
| Loss from warrant modification | - | - | - | -205,500 |
| Change in fair value of share payable | -118,000 | -240,000 | -23,000 | -60,500 |
| Change in fair value of convertible notes | -15,000 | 2,392,000 | 3,697,000 | 2,020,250 |
| Loss from extinguishment of debt | -4,004,000 | -4,516,000 | -7,282,000 | -3,329,500 |
| Loss from issuance of debt | -1,611,000 | -773,000 | - | -208,750 |
| Interest expense | 2,621,000 | 1,826,000 | 1,602,000 | 2,003,000 |
| Foreign currency transaction gain (loss) | -808,000 | - | - | - |
| Total other expense | -12,509,000 | -599,000 | -2,032,000 | -6,146,000 |
| Net loss | -26,829,000 | -15,378,000 | -19,343,000 | -23,267,500 |
| Deemed dividend related to warrant modifications | 353,000 | 560,000 | 265,000 | 420,500 |
| Net loss attributable to common stockholders | -27,182,000 | -15,938,000 | -19,608,000 | -23,688,000 |
| Foreign currency translation adjustment | -632,000 | 3,248,000 | 1,644,000 | 2,013,250 |
| Total comprehensive loss | -26,550,000 | -19,186,000 | -21,252,000 | -20,921,250 |
| Earnings per share, basic | -0.02 | -0.01 | -0.01 | -0.015 |
| Earnings per share, diluted | -0.02 | -0.01 | -0.01 | -0.015 |
| Weighted average number of shares outstanding, basic | 1,492,079 | 1,438,198 | 1,359,496 | -615,305.5 |
| Weighted average number of shares outstanding, diluted | 1,492,079 | 1,438,198 | 1,359,496 | -615,305.5 |
NORTHWEST BIOTHERAPEUTICS INC (NWBO)
NORTHWEST BIOTHERAPEUTICS INC (NWBO)